| Product Code: ETC13220968 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America DNA Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America DNA Diagnostics Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America DNA Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 North America DNA Diagnostics Market - Industry Life Cycle |
3.4 North America DNA Diagnostics Market - Porter's Five Forces |
3.5 North America DNA Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America DNA Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 North America DNA Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 North America DNA Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America DNA Diagnostics Market Trends |
6 North America DNA Diagnostics Market, 2021 - 2031 |
6.1 North America DNA Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America DNA Diagnostics Market, Revenues & Volume, By Microarrays-based Diagnostics, 2021 - 2031 |
6.1.3 North America DNA Diagnostics Market, Revenues & Volume, By PCR-based Diagnostics, 2021 - 2031 |
6.1.4 North America DNA Diagnostics Market, Revenues & Volume, By In-situ Hybridization Diagnostics, 2021 - 2031 |
6.1.5 North America DNA Diagnostics Market, Revenues & Volume, By NGS DNA Diagnosis, 2021 - 2031 |
6.2 North America DNA Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America DNA Diagnostics Market, Revenues & Volume, By Cancer Genetics Tests, 2021 - 2031 |
6.2.3 North America DNA Diagnostics Market, Revenues & Volume, By Infectious Diseases DNA Testing, 2021 - 2031 |
6.2.4 North America DNA Diagnostics Market, Revenues & Volume, By Newborn Genetic Screening, 2021 - 2031 |
6.2.5 North America DNA Diagnostics Market, Revenues & Volume, By Preimplantation & Reproductive Diagnosis, 2021 - 2031 |
6.2.6 North America DNA Diagnostics Market, Revenues & Volume, By Non-Infectious Diseases DNA Testing, 2021 - 2031 |
6.2.7 North America DNA Diagnostics Market, Revenues & Volume, By Prenatal DNA Carrier Screening, 2021 - 2031 |
6.2.8 North America DNA Diagnostics Market, Revenues & Volume, By Pharmacogenomics/Drug Metabolism, 2021 - 2031 |
6.2.9 North America DNA Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America DNA Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America DNA Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.1 United States (US) DNA Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.2 Canada DNA Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.3 Rest of North America DNA Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3 North America DNA Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United States (US) DNA Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Canada DNA Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Rest of North America DNA Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
8 North America DNA Diagnostics Market Key Performance Indicators |
9 North America DNA Diagnostics Market - Export/Import By Countries Assessment |
10 North America DNA Diagnostics Market - Opportunity Assessment |
10.1 North America DNA Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America DNA Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.3 North America DNA Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
11 North America DNA Diagnostics Market - Competitive Landscape |
11.1 North America DNA Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 North America DNA Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here